Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Innate Immun ; 18(1): 164-70, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21239459

ABSTRACT

Chronic low-grade infection has been suggested to be associated with metabolic disorder such as diabetes. However, the molecular mechanism underlying this important association is largely unknown. The only clue established so far is that many subjects exhibit elevated levels of C-reactive protein as measured by highly sensitive assay. Here, we hypothesized that adipocyte-macrophage interaction plays a key role in amplifying such low grade infection to the level of influencing metabolic disorders. The presence of macrophages in abdominal adipose tissues was investigated by immunohistochemistry. To see whether molecules associated with acute phase protein, LPS signaling, and persistent recruitment of monocytes, are produced at higher amounts in adipocytes co-cultured with macrophages stimulated with low concentration of LPS (1 ng/ml), we measured serum amyloid A (SAA), LPS binding protein (LBP), soluble CD14 (sCD14), and RANTES levels in culture supernatant of co-cultures. Lastly, we investigated in vivo effect of low-grade LPS infusion on the production of these molecules using obese model mice. The macrophages were certainly identified in abdominal adipose tissues. Investigated molecules, especially LBP, SAA, and RANTES were produced at higher amounts in co-cultures stimulated with LPS compared with the cells without LPS. The ob/ob, and high-fat diet-induced obesity mice produced higher amounts of LBP, SAA, and RANTES one day after LPS infusion (1 ng/ml/g body weight) compared with ob/- and normal-fat fed control mice. Thus, adipocytes and infiltrated macrophages, and their interaction with low endotoxin stimulation appear to play an important role in amplifying and maintaining LPS-induced low-grade inflammation.


Subject(s)
Adipocytes/metabolism , Lipid Metabolism Disorders/genetics , Lipid Metabolism Disorders/immunology , Macrophages/metabolism , Abdominal Fat/pathology , Acute-Phase Proteins/genetics , Acute-Phase Proteins/metabolism , Adipocytes/immunology , Adipocytes/pathology , Animals , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Communication , Cells, Cultured , Chemokine CCL5/genetics , Chemokine CCL5/metabolism , Coculture Techniques , Diet, High-Fat , Disease Models, Animal , Gene Expression Regulation , Humans , Inflammation/immunology , Leptin/genetics , Lipid Metabolism Disorders/chemically induced , Lipopolysaccharide Receptors/genetics , Lipopolysaccharide Receptors/metabolism , Lipopolysaccharides/administration & dosage , Macrophages/immunology , Macrophages/pathology , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Mice , Mice, Knockout , Mice, Obese , Serum Amyloid A Protein/genetics , Serum Amyloid A Protein/metabolism
2.
Metabolism ; 60(6): 823-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20817211

ABSTRACT

Although periodontal disease may be associated with increased risk for atherosclerosis, the mechanism by which the disease causes atherosclerosis is still unknown. The candidates contributing to atherosclerosis in periodontal disease include low-grade inflammation such as C-reactive protein (CRP) and insulin resistance. A previous study demonstrated that periodontal therapy leads to an improvement in CRP as well as insulin resistance, indicating the relationship between periodontal disease and low-grade inflammation or insulin resistance. On the other hand, we previously demonstrated that serum triglyceride (TG) per se is independently associated with CRP or insulin resistance in Japanese populations with a body mass index (BMI) of 21.5 to 27.0 (midrange BMI). To the best of our knowledge, however, the relationship between periodontal disease and serum TG is not fully clarified. The first aim of the present study is to investigate whether periodontal disease is associated with serum TG in Japanese subjects with midrange BMI. If so, another aim of the study is to determine which mechanism is responsible for the association between periodontal disease and serum TG in these subjects. We have performed a periodontal examination in the Ogaki metabolic syndrome medical examination. One hundred sixty-two participants from 40 to 74 years old (56 men and 106 women; mean age, 66.43 ± 6.25 years) were enrolled in the study. Besides medical examination, oral panoramic radiograph was taken for all participants. Average bone score was also calculated. Periodontal bone destruction increased according to the age of the participants (r = 0.227, P < .004, Spearman correlation coefficient). Periodontal bone destruction was also associated with serum TG levels (r = 0.299, P = .000). This association was more evident in subjects with midrange BMI (r = 0.332, P < .001). In subjects with midrange BMI, TG was not correlated with BMI or waste circumstances. Furthermore, TG was not associated with age itself in the midrange BMI group. We then investigated the lipolytic activity of endotoxin in cocultures of adipocytes and macrophages. Low-dose lipopolysaccharide dose-dependently increased lipolytic activity in cocultures, and this activity was neutralized by anti-tumor necrosis factor α neutralizing antibodies. These results suggest that periodontal infection, especially bacterial endotoxinemia, is associated with enhanced lipolysis and subsequent up-regulation of circulating TG in Japanese with midrange BMI.


Subject(s)
Hypertriglyceridemia/metabolism , Lipolysis/physiology , Periodontal Diseases/metabolism , 3T3-L1 Cells , Adult , Aged , Alveolar Bone Loss/complications , Alveolar Bone Loss/pathology , Animals , Antibodies, Blocking/pharmacology , Body Mass Index , Coculture Techniques , Dose-Response Relationship, Drug , Endotoxins/analysis , Female , Humans , Hypertriglyceridemia/complications , Hypertriglyceridemia/epidemiology , Japan/epidemiology , Lipolysis/drug effects , Lipopolysaccharides/pharmacology , Macrophages/metabolism , Male , Mice , Middle Aged , Periodontal Diseases/complications , Periodontal Diseases/pathology , Triglycerides/blood , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Waist Circumference/physiology
3.
Clin Chem ; 48(7): 1043-8, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12089173

ABSTRACT

BACKGROUND: There are large individual variations in the responses of risk factors for coronary heart disease to alcohol consumption. To clarify the factors responsible for these individual variations, we studied the relationship between blood pressure, serum lipids, and uric acid and the genetic polymorphisms of alcohol dehydrogenase (ADH) 2 and aldehyde dehydrogenase (ALDH) 2 in alcohol drinkers. METHODS: We examined 133 male workers who drank >300 g of alcohol per week. Information regarding lifestyle habits was obtained by questionnaire. The ADH2 genotype was determined by PCR and subsequent digestion with MaeIII. The ALDH2 genotype was determined based on amplified product length polymorphisms. RESULTS: When the workers were divided into three groups: the ADH2(1)/2(1), ADH2(1)/2(2), and ADH2(2)/2(2) groups, the mean triglycerides and gamma-glutamyl transpeptidase concentrations were significantly higher in the ADH2(2)/2(2) group than in the ADH2(1)/2(1) group. In addition, multiple logistic regression analysis showed that the frequencies of individuals whose systolic blood pressure, triglycerides, and uric acid values were in the highest one third were significantly higher in the ADH2(2)/2(2) group than in the ADH2(1)/2(1) group. In contrast, no difference was observed between the ALDH2(1)/2(1) and (ALDH2(1)/2(2) + ALDH2(2)/2(2)) groups with regard to the mean value of any variable and to the frequency of individuals with any variable value in the highest one third. CONCLUSION: Individuals with the ADH2(1)/2(1) genotype might suffer fewer negative effects of drinking.


Subject(s)
Alcohol Dehydrogenase/genetics , Alcohol Drinking/adverse effects , Aldehyde Dehydrogenase/genetics , Coronary Disease/diagnosis , Blood Pressure , Coronary Disease/etiology , Genotype , Humans , Lipids/blood , Male , Middle Aged , Polymorphism, Genetic , Risk Factors , Uric Acid/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...